Artificial Intelligence in Drug Treatment

被引:28
|
作者
Romm, Eden L. [1 ]
Tsigelny, Igor F. [1 ,2 ]
机构
[1] CureMatch Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 | 2020年 / 60卷
关键词
artificial intelligence; machine learning; deep learning; personalized medicine; drug combination; combination therapy; BLOOD-BRAIN-BARRIER; FEATURE-SELECTION; PREDICTION; IDENTIFICATION; OPTIMIZATION; POLYPHARMACY; DESCRIPTORS; DATABASE;
D O I
10.1146/annurev-pharmtox-010919-023746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The most common applications of artificial intelligence (AI) in drug treatment have to do with matching patients to their optimal drug or combination of drugs, predicting drug-target or drug-drug interactions, and optimizing treatment protocols. This review outlines some of the recently developed AI methods aiding the drug treatment and administration process. Selection of the best drug(s) for a patient typically requires the integration of patient data, such as genetics or proteomics, with drug data, like compound chemical descriptors, to score the therapeutic efficacy of drugs. The prediction of drug interactions often relies on similarity metrics, assuming that drugs with similar structures or targets will have comparable behavior or may interfere with each other. Optimizing the dosage schedule for administration of drugs is performed using mathematical models to interpret pharmacokinetic and pharmacodynamic data. The recently developed and powerful models for each of these tasks are addressed, explained, and analyzed here.
引用
收藏
页码:353 / 369
页数:17
相关论文
共 50 条
  • [31] Artificial intelligence in the diagnosis, treatment and prevention of urinary stones
    Yang, Bob
    Veneziano, Domenico
    Somani, Bhaskar K.
    CURRENT OPINION IN UROLOGY, 2020, 30 (06) : 782 - 787
  • [32] Trends and Application of Artificial Intelligence Technology in Orthodontic Diagnosis and Treatment Planning-A Review
    Albalawi, Farraj
    Alamoud, Khalid A.
    APPLIED SCIENCES-BASEL, 2022, 12 (22):
  • [33] Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics
    Koromina, Maria
    Pandi, Maria-Theodora
    Patrinos, George P.
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2019, 23 (11) : 539 - 548
  • [34] Trends of Artificial Intelligence (AI) Use in Drug Targets, Discovery and Development: Current Status and Future Perspectives
    Mahapatra, Manmayee
    Sahu, Chittaranjan
    Mohapatra, Snehamayee
    CURRENT DRUG TARGETS, 2024,
  • [35] Artificial intelligence and cheminformatics tools: a contribution to the drug development and chemical science
    Saifi, Ifra
    Bhat, Basharat Ahmad
    Hamdani, Syed Suhail
    Bhat, Umar Yousuf
    Lobato-Tapia, Carlos Alberto
    Mir, Mushtaq Ahmad
    Dar, Tanvir Ul Hasan
    Ganie, Showkat Ahmad
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (12) : 6523 - 6541
  • [36] Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
    Arshadi, Arash Keshavarzi
    Webb, Julia
    Salem, Milad
    Cruz, Emmanuel
    Calad-Thomson, Stacie
    Ghadirian, Niloofar
    Collins, Jennifer
    Diez-Cecilia, Elena
    Kelly, Brendan
    Goodarzi, Hani
    Yuan, Jiann Shiun
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2020, 3
  • [37] Drug repositioning for Parkinson's disease: An emphasis on artificial intelligence approaches
    Karimi-Sani, Iman
    Sharifi, Mehrdad
    Abolpour, Nahid
    Lotfi, Mehrzad
    Atapour, Amir
    Takhshid, Mohammad-Ali
    Sahebkar, Amirhossein
    AGEING RESEARCH REVIEWS, 2025, 104
  • [38] Elucidating the role of artificial intelligence in drug development from the perspective of drug-target interactions
    Wang, Boyang
    Zhang, Tingyu
    Liu, Qingyuan
    Sutcharitchan, Chayanis
    Zhou, Ziyi
    Zhang, Dingfan
    Li, Shao
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2025, 15 (03)
  • [39] Artificial intelligence in the early stages of drug discovery
    Cavasotto, Claudio N.
    Di Filippo, Juan I.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 698
  • [40] Artificial intelligence to deep learning: machine intelligence approach for drug discovery
    Rohan Gupta
    Devesh Srivastava
    Mehar Sahu
    Swati Tiwari
    Rashmi K. Ambasta
    Pravir Kumar
    Molecular Diversity, 2021, 25 : 1315 - 1360